BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 2, 2007
View Archived Issues
ABT-737 sensitizes AML cells to Flt3 inhibitor
Read More
mGluR2/3 antagonist LY-341495 exerts antidepressant activity in rodents
Read More
Rhein Biotech shareholders approve merger with Berna Rhein
Read More
Oncolytics Biotech begins new Reolysin studies
Read More
Azilect disease modification study in early Parkinson's completes enrollment
Read More
S-7701 significantly inhibits worsening of IPF in Japanese studies
Read More
Zadaxin plus DTIC improves survival in stage IV malignant melanoma
Read More
Grazax shows improved effect in second treatment season of study
Read More
Encouraging results for removab in malignant ascites in ovarian cancer patients
Read More
Insulin resistance may result from impaired cytohesin function
Read More
AstraZeneca to continue development of AZD-3480
Read More
CoFactor and 5-FU studied in refractory metastatic breast cancer
Read More
ThromboGenics and BioInvent receive funding for antiangiogenesis program
Read More
Omrix highlights Q4 milestones
Read More
Sunitinib filed in Japan for renal carcinoma and gastrointestinal stromal tumors
Read More
Vectura signs U.S. collaboration for VR-315 combination asthma therapy
Read More
Phase III Zadaxin triple therapy study in HCV completes enrollment
Read More
KSP inhibitor ARRY-520 to begin clinical testing
Read More
Sirna shareholders approve acquisition by Merck & Co.
Read More
Bioenvision prepares MAA for Evoltra in AML
Read More
KRX-0401 studied with Revlimid and dexamethasone for multiple myeloma
Read More
FDA accepts complete response to Thelin NDA
Read More
Novel analgesic agents revealed in recent patents
Read More
Molecular function of Cdk5 in pain signaling elucidated
Read More
Recent patents describe novel agents for metabolic disorders
Read More
Novel compounds discovered with potential use in neurological disorders
Read More
Approvable letter for Pennsaid
Read More